Abstract
World Health Organization-classified very severe pneumonia due to Pneumocystis jirovecii infection is recognized as a life-threatening condition in human immunodefi ciency virus (HIV) infected infants. We recount the use of nasal bubble continuous positive airway pressure (BCPAP) in an HIV-infected African infant with very severe pneumonia and treatment failure due to suspected infection with P. jirovecii. We also examine the potential implications of BCPAP use in resource-poor settings with a high case index of acute respiratory failure due to HIV-related pneumonia, but limited access to mechanical ventilation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 562-564 |
| Number of pages | 3 |
| Journal | International Journal of Tuberculosis and Lung Disease |
| Volume | 15 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2011 |
| Externally published | Yes |
Fingerprint
Keywords
- BCPAP
- Early infant diagnosis
- HIV
- Pneumocystis jirovecii pneumonia
- Sub-Saharan Africa
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Infectious Diseases
Cite this
Bubble continuous positive airway pressure in a human immunodeficiency virus-infected infant. / McCollum, Eric; Smith, A.; Golitko, C. L.
In: International Journal of Tuberculosis and Lung Disease, Vol. 15, No. 4, 04.2011, p. 562-564.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Bubble continuous positive airway pressure in a human immunodeficiency virus-infected infant
AU - McCollum, Eric
AU - Smith, A.
AU - Golitko, C. L.
PY - 2011/4
Y1 - 2011/4
N2 - World Health Organization-classified very severe pneumonia due to Pneumocystis jirovecii infection is recognized as a life-threatening condition in human immunodefi ciency virus (HIV) infected infants. We recount the use of nasal bubble continuous positive airway pressure (BCPAP) in an HIV-infected African infant with very severe pneumonia and treatment failure due to suspected infection with P. jirovecii. We also examine the potential implications of BCPAP use in resource-poor settings with a high case index of acute respiratory failure due to HIV-related pneumonia, but limited access to mechanical ventilation.
AB - World Health Organization-classified very severe pneumonia due to Pneumocystis jirovecii infection is recognized as a life-threatening condition in human immunodefi ciency virus (HIV) infected infants. We recount the use of nasal bubble continuous positive airway pressure (BCPAP) in an HIV-infected African infant with very severe pneumonia and treatment failure due to suspected infection with P. jirovecii. We also examine the potential implications of BCPAP use in resource-poor settings with a high case index of acute respiratory failure due to HIV-related pneumonia, but limited access to mechanical ventilation.
KW - BCPAP
KW - Early infant diagnosis
KW - HIV
KW - Pneumocystis jirovecii pneumonia
KW - Sub-Saharan Africa
UR - http://www.scopus.com/inward/record.url?scp=79952782199&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952782199&partnerID=8YFLogxK
U2 - 10.5588/ijtld.10.0583
DO - 10.5588/ijtld.10.0583
M3 - Article
C2 - 21396221
AN - SCOPUS:79952782199
VL - 15
SP - 562
EP - 564
JO - International Journal of Tuberculosis and Lung Disease
JF - International Journal of Tuberculosis and Lung Disease
SN - 1027-3719
IS - 4
ER -